From medicine shortages to over regulation and anomalies in global approvals for biosimilars, Richard Daniell, Teva’s EVP Europe Commercial & Global Generics Franchise, outlines the key trends in the generic medicines field: https://ow.ly/8mmA50T9wKm
概要
Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com. Please note that adverse effects for any of our products should be reported to: [email protected] Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/
- ウェブサイト
-
http://www.tevapharm.com
Teva Pharmaceuticalsの外部リンク
- 業種
- 医薬品製造業
- 会社規模
- 社員 10,001名以上
- 本社
- Tel-Aviv
- 種類
- 上場企業
- 専門分野
- generic medicines、specialty medicines、CNS、active pharmaceutical ingredients、respiratory、biosimilars、biologics、pain care、migraine、oncology
場所
Teva Pharmaceuticalsの社員
アップデート
-
What is Teva’s Pivot to Growth strategy? Discover the four key pillars behind Teva’s growth, from new innovations in treatments for diseases that are on the rise worldwide to supporting patients with conditions including schizophrenia and migraine. Our strategy speaks to our Teva nature – being all in for better health, we work together to achieve remarkable things. Our direction is clear, and we are committed to keep raising the bar, in service of our patients, customers and healthcare systems. Discover more: https://ow.ly/6aZN50T6ko8 #PivotToGrowth #WeAreAllInForBetterHealth #Innovation #Tevapharm
-
-
Addressing global challenges, such as climate change, requires collective effort. At Teva, we recognize the importance of partnering with businesses that share our vision. That’s why we published an updated letter of intent for our suppliers, describing our shared approach to #sustainability: https://ow.ly/oP2M50T5ZeI Here are some of the expectations we set: 🤝 Aligning with our Supplier Code of Conduct, policies and positions and participating in PSCI - Pharmaceutical Supply Chain Initiative audits 🌎 Establishing greenhouse gas emissions reduction targets in line with the Science Based Targets initiative (SBTi) and becoming SBTi approved by 2025 💊 Completing AMR Industry Alliance assessments to ensure responsible production of antibiotics Together, we can shape the future we want to see. #ProcurementExcellence #Tevapharm
-
-
Happy International Dog Day! 🐾🐕🦺 Today, we celebrate our loyal companions who bring so much joy and comfort into our lives. Did you know that spending time with animals can improve your wellbeing, lower your stress levels, and sometimes even soothe physical and emotional pain? Read about the power of pet therapy from patients, caregivers and employees: https://ow.ly/37SM50T6jIT Do you have a dog? Share their photo in the comments – we’d love to meet them! #InternationalDogDay #DogLovers #Tevapharm
-
-
What are the top trends in global manufacturing and supply chains? Join Dan Pritchett, VP for External Manufacturing and Supply Operations at Teva North America, as he explores the latest directions in simplifying complex supply chains, moves towards high value project in North America and Europe, and more: https://ow.ly/Vc8t50T3JiZ #GlobalManufacturing #IndustryTrends #Tevapharm
-
Congratulazioni! 🎉 We're happy to share that Teva Italy has achieved the prestigious Gender Equality Certification! This achievement underscores our commitment to fostering a more inclusive workplace for everyone, and we're proud to lead the charge towards creating a more equitable future. If that’s not a reason to smile, we don’t know what is! 😁 #Tevapharm #GenderEquality #InclusionAndDiversity
-
“Tip #3: Creating a calm environment is essential. Dim the lights, keep noise levels low, and avoid strong smells to help your loved one manage their migraine.” Watching your loved one go through a migraine attack can be a sad and panic-inducing situation. There are few things worse than seeing someone close to you go through so much pain and be unable to take it away. But there are several practical ways you can support a loved one through a migraine attack. Today, migraineur Sarah Alexander-Georgeson shares 7 tips for family and friends who want to help. Read Sarah’s 7 tips here: https://ow.ly/f2Tu50SQGFs #MigraineSupport #MigraineAwareness #MigraineTips #Tevapharm
-
Who knew pharmaceuticals could sound so good? 🤩 Our mixtape is a dose of inspiration, energy, and innovation, just like the work we do every day. What song would you add? Share your track in the comments. 🎶 #TevaPharm #TevaCareers
-
-
Meet Jessica Buttkus and Shachaf Shapira, two of Teva's dedicated graduate team members who are making a difference every day! 👩🎓 Jessica's passion for healthcare and leadership shines through her transition from a project manager in Teva Biotech Ulm, Germany, to the commercial business unit. Despite stepping out of her comfort zone, she’s demonstrating adaptability and a commitment to growth in every aspect of her role. 👨🔬 Shachaf's dream of bridging academic knowledge with real-world impact led her to Teva's R&D in Netanya, Israel. From quality assurance to pharmacovigilance, she's embracing every opportunity for growth and learning. Learn more about Jessica and Shachaf’s journeys here > https://ow.ly/Ele950SQGKm #TevaTalent #Leadership #InnovationJourney #Tevapharm
-
-
Making medicines is traditionally a long, costly and risky process with the cost of making a medicine rising from $179 million in the 1970s to 1 billion in the 2000s and up to $2.6 billion today. But new innovations such as machine learning and AI technology can help overcome traditional inefficiencies in the drug development system. Teva’s Chief Medical Officer Eric A. Hughes, MD, PhD outlines a few of the most exciting possibilities: https://ow.ly/Tj0J50SQGCy #Innovation #PharmaInnovation #DrugDevelopment #MedicalInnovation #AIinHealthcare #Tevapharm
-